The January 2024 newsletter features the new ARLG Innovation and Evolution Supplement Published in Clinical Infectious Diseases, exciting honors for Kerry LaPlante, PharmD, FCCP, FIDSA, FIDP and Robin Patel, MD, a spotlight on Darek Hareza, MD, MHS, the SNAP study summary of results, and more!
A primary goal of the ARLG is to train the next generation of researchers who will help reduce the public health threat of antibacterial resistance.
LEARN MORE